Cullinan Oncology Inc (cgem.o)

+ 收藏

资产负债表(Cullinan Oncology Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
截止日期 2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-31
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 1231123112311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后上市后上市后
流动资产:
 现金及现金等价物(元) 会员可见会员可见会员可见会员可见115,021,000.0074,228,000.0098,434,000.0064,847,000.00141,834,000.00122,128,000.00
 预付款项及其他应收款流动(元) 会员可见会员可见会员可见会员可见15,304,000.0012,710,000.0013,124,000.0010,282,000.006,437,000.008,331,000.00
 短期投资(元) 会员可见会员可见会员可见会员可见547,474,000.00358,783,000.00368,633,000.00401,583,000.00349,964,000.00268,572,000.00
 流动资产合计(元) 会员可见会员可见会员可见会员可见677,799,000.00445,721,000.00480,191,000.00476,712,000.00498,235,000.00399,031,000.00
非流动资产:
 物业、厂房及设备(元) 会员可见会员可见会员可见会员可见836,000.00913,000.00989,000.001,066,000.001,158,000.001,239,000.00
 长期投资(元) 会员可见会员可见会员可见会员可见---13,545,000.0018,631,000.00110,442,000.00
 非流动资产其他项目(元) 会员可见会员可见会员可见会员可见2,581,000.002,796,000.003,002,000.003,384,000.003,960,000.004,278,000.00
 非流动资产合计(元) 会员可见会员可见会员可见会员可见3,417,000.003,709,000.003,991,000.0017,995,000.0023,749,000.00115,959,000.00
总资产(元) 会员可见会员可见会员可见会员可见681,216,000.00449,430,000.00484,182,000.00494,707,000.00521,984,000.00514,990,000.00
流动负债:
 融资租赁负债流动(元) 会员可见会员可见会员可见会员可见1,215,000.001,329,000.001,440,000.001,547,000.001,652,000.001,554,000.00
 应付账款及票据(元) 会员可见会员可见会员可见会员可见1,555,000.003,707,000.002,493,000.00951,000.002,493,000.002,031,000.00
 应付税项流动(元) ---------4,207,000.00
 其他应付款及应计费用(元) 会员可见会员可见会员可见会员可见20,706,000.0016,889,000.0024,204,000.0020,946,000.0015,531,000.0018,379,000.00
 流动负债合计(元) 会员可见会员可见会员可见会员可见23,476,000.0021,925,000.0028,137,000.0023,444,000.0019,676,000.0026,171,000.00
非流动负债:
 融资租赁负债非流动(元) 会员可见会员可见会员可见会员可见1,519,000.001,840,000.002,150,000.002,446,000.002,734,000.003,170,000.00
 非流动负债合计(元) 会员可见会员可见会员可见会员可见1,519,000.001,840,000.002,150,000.002,446,000.002,734,000.003,170,000.00
总负债(元) 会员可见会员可见会员可见会员可见24,995,000.0023,765,000.0030,287,000.0025,890,000.0022,410,000.0029,341,000.00
股东权益:
 普通股(元) 会员可见会员可见会员可见会员可见6,000.004,000.004,000.004,000.004,000.004,000.00
 股本溢价(元) 会员可见会员可见会员可见会员可见936,724,000.00663,997,000.00654,685,000.00646,918,000.00639,066,000.00592,544,000.00
 留存收益(元) 会员可见会员可见会员可见会员可见-280,033,000.00-238,005,000.00-200,857,000.00-177,054,000.00-137,871,000.00-105,657,000.00
 累计其他全面收益(元) 会员可见会员可见会员可见会员可见-476,000.00-331,000.00-129,000.00-1,051,000.00-1,625,000.00-1,242,000.00
 归属于母公司股东权益(元) 会员可见会员可见会员可见会员可见656,221,000.00425,665,000.00453,703,000.00468,817,000.00499,574,000.00485,649,000.00
 少数股东权益(元) ------192,000.00---
 股东权益合计(元) 会员可见会员可见会员可见会员可见656,221,000.00425,665,000.00453,895,000.00468,817,000.00499,574,000.00485,649,000.00
负债及股东权益合计(元) 会员可见会员可见会员可见会员可见681,216,000.00449,430,000.00484,182,000.00494,707,000.00521,984,000.00514,990,000.00
公告日期 2025-08-072025-05-082025-02-272024-11-072024-08-082024-05-152024-03-142023-11-082023-08-102023-05-11
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院